| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Molecular Biology & Genetics [G. J. C., A. P. F.], Medicine [J. S. T., B-A. R., J-Y. L., A. P. F.], and Oncology [A. P. F.], Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Genomic imprinting is an epigenetic modification in the germline leading to parental allele-specific gene expression in somatic cells. We have previously found that imprinted genes can be abnormally expressed or silenced in tumors and that the cyclin-dependent kinase inhibitor (CKI) CDKN1C (p57KIP2) is normally imprinted, with preferential expression of the maternal allele. Here we analyze the imprinting status of three additional CKIs, the abnormal expression and/or chromosomal localization of which has been implicated in human malignancy: CDKN1A, CDKN1B, and CDKN2C. Allele-specific expression was examined by reverse transcription-PCR, using primers that span transcribed polymorphisms as well as exon/intron boundaries, to distinguish cDNA products from genomic DNA. Biallelic expression was observed for all three genes in both fetal and adult tissues. Thus, genomic imprinting is not a generalized feature of CKIs.
1 This work was supported by NIH Grant CA65145 (to A. P. F.) and Biochemistry and Cellular & Molecular Biology Training Grant GM07445 (to G. J. C.).
2 To whom requests for reprints should be addressed, at Johns Hopkins University School of Medicine, Ross 1064, 720 Rutland Avenue, Baltimore, MD 21205. Phone: (410) 614-3489; Fax: (410) 614-9819.
Received 12/13/96. Accepted 1/ 6/97.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |